Abstract:Background Alterations in serum creatinine levels delay the identification of severe cardiac surgery‐associated acute kidney injury. To provide timely diagnosis, novel predictive tools should be investigated. Methods and Results This prospective observational study consists of a screening cohort (n=204) and a validation cohort (n=198) from 2 centers from our hospital. Thirty‐two inflammatory cytokines were measured via a multiplex cytokine assay. Least absolute shrinkage and selection operator regression was conducted to select the cytokine signatures of severe cardiac surgery‐associated acute kidney injury. Afterwards, the significant candidates including interferon‐γ, interleukin‐16, and MIP‐1α (macrophage inflammatory protein‐1 alpha) were integrated into the logistic regression model to construct a predictive model. The predictive accuracy of the model was evaluated in these 2 cohorts. The cytokine‐based model yielded decent performance in both the screening (C‐statistic: 0.87, Brier 0.10) and validation cohorts (C‐statistic: 0.86, Brier 0.11). Decision curve analysis revealed that the cytokine‐based model had a superior net benefit over both the clinical factor‐based model and the established plasma biomarker‐based model for predicting severe acute kidney injury. In addition, elevated concentrations of each cytokine were associated with longer mechanical ventilation times, intensive care unit stays, and hospital stays. They strongly predicted the risk of composite events (defined as treatment with renal replacement therapy and/or in‐hospital death) (OR of the fourth versus the first quartile [95% CI]: interferon‐γ, 27.78 [3.61–213.84], interleukin‐16, 38.07 [4.98–291.07], and MIP‐1α, 9.13 [2.84–29.33]). Conclusions Our study developed and validated a promising blood cytokine‐based model for predicting severe acute kidney injury after cardiac surgery and identified prognostic biomarkers for assisting in outcome risk stratification. Nonstandard Abbreviations and Acronyms AKI acute kidney injury CSA‐AKI cardiac surgery‐associated acute kidney injury ICU intensive care unit Clinical Perspective What Is New? Patients who developed severe acute kidney injury after cardiac surgery had distinct blood immune‐inflammatory cytokines signatures within 12 to 24 hours after surgery. A novel cytokine‐based predictive model incorporating interferon‐γ, interleukin‐16, and MIP‐1α (macrophage inflammatory protein‐1 alpha) successfully predicted severe cardiac surgery‐associated ‐acute kidney injury). Interferon‐γ, interleukin‐16, and MIP‐1α were all capable of predicting poor outcomes after cardiac surgery. What Are the Clinical Implications? Increased plasma concentrations of interferon‐γ, interleukin‐16, and MIP‐1α each predict higher risk for severe cardiac surgery‐associated‐acute kidney injury. Alterations in plasma immune‐inflammatory cytokine concentrations demonstrate promise for early identification of patients likely to develop severe cardiac surgery‐associated‐acute kidney injury. Acute kidney injury (AKI) is one of the major adverse complications frequently occurring after cardiac surgery. 1 Globally, ≈5% to 42% of patients undergoing cardiac surgery experience AKI. 2 Patients with severe AKI are confronted with a 3‐ to 8‐fold higher perioperative mortality, prolonged length of intensive care unit (ICU) and hospital stay, and an increased cost of health care. 3 Moreover, as reported, cardiac surgery‐associated acute kidney injury (CSA‐AKI) was the second leading condition for AKI in the intensive care setting and contributed to increased mortality. 4 Currently, because of a general lack of effective treatments for severe CSA‐AKI, the earlier identification of the condition will offer clinicians essential guidance on the prevention and management of the syndrome. Given that traditional clinical diagnosis based on serum creatinine alterations and clinical risk facto -Abstract Truncated-

Mechanism and clinical role of TIMP-2 and IGFBP-7 in cardiac surgery-associated acute kidney injury: A review

Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein 7 (IGFBP7) for the prediction of acute kidney injury following cardiac surgery

Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review

Urinary TIMP-2 and IGFBP7 for the Prediction of Acute Kidney Injury Following Cardiac Surgery

Risk factors for perioperative acute kidney injury in adult cardiac valve surgery with cardiopulmonary bypass

Impact of Cardiac Function Improvement on Cardiac Surgery Associated Acute Kidney Injury for Patients with Preoperative Renal Dysfunction

The incidence, risk factors, and prognosis of acute kidney injury in patients after cardiac surgery

Biomarkers of Acute Kidney Injury after Cardiac Surgery: A Narrative Review

[Advances in the clinical value of tissue inhibitors of metalloproteinase-2 and insulin-like growth factor binding protein 7 in sepsis associated-acute kidney injury].

Serum Insulin-Like Growth Factor-Binding Protein 7 Deriving from Spleen and Lung Could Be Used for Early Recognition of Cardiac Surgery-Associated Acute Kidney Injury.

Management of Cardiac Surgery-Associated Acute Kidney Injury.

Prevention of cardiac surgery-associated acute kidney injury

Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin

Novel Blood Cytokine-Based Model for Predicting Severe Acute Kidney Injury and Poor Outcomes After Cardiac Surgery.

The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery

[The Risk Factors and Prognosis of Acute Kidney Injury after Cardiac Surgery: a Prospective Cohort Study of 4007 Cases].

Risk Factors for Long-Term Mortality and Progressive Chronic Kidney Disease Associated With Acute Kidney Injury After Cardiac Surgery.

Perioperative Urinary TIMP-2*IGFBP7 and Acute Kidney Injury: A Systematic Review

Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment

Evaluation of acute kidney injury by urinary tissue inhibitor metalloproteinases-2 and insulin-like growth factor-binding protein 7 after pediatric cardiac surgery

[A Long-Term Outcome Study of Acute Kidney Injury after Cardiac Surgery].